Researchers at the Icahn School of Medicine at Mount Sinai and their collaborators have developed a new technology to track beneficial bacteria after fecal microbiota transplants (FMT). The approach ...
Fecal microbiota transplantation with anaerobic cultivated human intestinal microbiome (ACHIM) was well tolerated in patients with systemic sclerosis but showed no significant improvement over placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback